...
首页> 外文期刊>Neuropharmacology >Cisplatin increases brain 2-arachidonoylglycerol (2-AG) and concomitantly reduces intestinal 2-AG and anandamide levels in the least shrew.
【24h】

Cisplatin increases brain 2-arachidonoylglycerol (2-AG) and concomitantly reduces intestinal 2-AG and anandamide levels in the least shrew.

机译:顺铂增加了大脑中2-花生四烯酸甘油酯(2-AG)的含量,并同时减少了最少的2-中肠道2-AG和an南酰胺的水平。

获取原文
获取原文并翻译 | 示例

摘要

The chemotherapeutic agent cisplatin may produce emesis via release of several neurotransmitters such as serotonin (5-HT), substance P and/or dopamine as well as production of prostaglandins (PGs). Administration of synthetic 2-arachidonoylglycerol (2-AG) but not of anandamide, which are two putative endocannabinoids, causes vomiting via its downstream metabolites such as arachidonic acid (AA) and PGs in the least shrew (Cryptotis parva). We report here that cisplatin (0, 5, 10 and 20 mg/kg, i.p.) causes dose- and time-dependent increases in brain tissue levels of 2-AG but not anandamide in this vomiting species. Concomitantly, intestinal tissue levels of both endocannabinoids are relatively reduced. Selective inhibitors [arachidonoyl-serotonin (AA-5-HT) and URB597, 0-5 and 0-10 mg/kg, i.p.] of one of the major endocannabinoid metabolic enzymes, the intracellular fatty acid amide hydrolase (FAAH), do not significantly prevent vomiting produced by emetic doses of i.p.-administered 2-AG, cisplatin or thedopamine receptor agonist apomorphine. At large doses (10 and 20 mg/kg, respectively), both FAAH inhibitors caused emesis per se. Administration of one selective uptake inhibitor of endocannabinoids, OMDM1 (0-5 mg/kg, i.p.), also did not significantly prevent emesis by the direct and indirect emetic stimuli, and likewise caused emesis by itself at a high (10 mg/kg) dose. However, another selective uptake inhibitor, VDM11, did not produce significant emesis per se and prevented emesis caused by apomorphine. Both the corticosteroid dexamethasone, and the cyclooxygenase inhibitor indomethacin, reduced vomiting produced by cisplatin. These data: (a) provide the first evidence that cisplatin causes a selective increase in 2-AG levels in the brain, and (b) support the established notion that 2-AG may produce some of its effects, including emesis, via downstream metabolites produced independently of FAAH.
机译:化疗药物顺铂可通过释放几种神经递质(例如5-羟色胺(5-HT),P物质和/或多巴胺)以及产生前列腺素(PGs)而产生呕吐。合成的2-花生四烯酰基甘油(2-AG)而不是anandamide的施用(这是两个假定的内源性大麻素)会通过其下游代谢产物(如花生四烯酸(AA)和PGs)在最少的sh(隐孢子虫)中引起呕吐。我们在这里报告说,顺铂(0、5、10和20 mg / kg,腹膜内)在这种呕吐物种中引起2-AG而不是阿南酰胺的脑组织水平的剂量和时间依赖性增加。同时,两种内源性大麻素的肠组织水平相对降低。主要内源性大麻素代谢酶之一细胞内脂肪酸酰胺水解酶(FAAH)的选择性抑制剂[花生四烯酸-血清素(AA-5-HT)和URB597,0-5和0-10 mg / kg,腹膜内)显着防止了催吐剂量的腹膜内注射2-AG,顺铂或多巴胺受体激动剂阿扑吗啡产生的呕吐。在大剂量(分别为10和20 mg / kg)下,两种FAAH抑制剂本身都会引起呕吐。给予一种选择性的内源性大麻素吸收抑制剂OMDM1(0-5 mg / kg,ip),也不能显着阻止直接和间接催吐刺激的呕吐,并且同样会以高剂量(10 mg / kg)引起呕吐剂量。但是,另一种选择性摄取抑制剂VDM11本身并不产生明显的呕吐,并且可以预防由阿扑吗啡引起的呕吐。皮质类固醇地塞米松和环氧合酶抑制剂吲哚美辛均可减少顺铂产生的呕吐。这些数据:(a)提供第一个证据证明顺铂会选择性地增加大脑中2-AG的水平,并且(b)支持已建立的观念,即2-AG可能通过下游代谢产物产生某些作用,包括呕吐。独立于FAAH生产。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号